Childhood neurodevelopmental difficulties and risk of adolescent depression: the role of irritability.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
08 2019
Historique:
accepted: 20 02 2019
pubmed: 26 3 2019
medline: 12 9 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Children with neurodevelopmental disorders are at increased risk of developing depression. Irritability predicts depression in the general population and is common in children with neurodevelopmental disorders. Thus, it is possible that irritability in children with neurodevelopmental disorders contributes to the link with later depression. This study aimed to (a) examine the association between childhood neurodevelopmental difficulties and adolescent depression and (b) test whether irritability explains this association. Children with any neurodevelopmental difficulty at the age of 7-9 (n = 1,697) and a selected, comparison group without any neurodevelopmental difficulty (n = 3,177) were identified from a prospective, UK population-based cohort, the Avon Longitudinal Study of Parents and Children. Neurodevelopmental difficulties were defined as a score in the bottom 5% of the sample on at least one measure of cognitive ability, communication, autism spectrum symptoms, attention-deficit/hyperactivity symptoms, reading or motor coordination. The Development and Well-Being Assessment measured parent-reported child irritability at the age of 7, parent-reported adolescent depression at the age of 10 and 13, and self-reported depression at the age of 15. Depression measures were combined, deriving an outcome of major depressive disorder (MDD) in adolescence. Logistic regression examined the association between childhood neurodevelopmental difficulties and adolescent MDD, controlling for gender. Path analysis estimated the proportion of this association explained by irritability. Analyses were repeated for individual neurodevelopmental problems. Childhood neurodevelopmental difficulties were associated with adolescent MDD (OR = 2.11, 95% CI = 1.24, 3.60, p = .006). Childhood irritability statistically accounted for 42% of this association. On examining each neurodevelopmental difficulty separately, autistic, communication and ADHD problems were each associated with depression, with irritability explaining 29%-51% of these links. Childhood irritability appears to be a key contributor to the link between childhood neurodevelopmental difficulties and adolescent MDD. High rates of irritability in children with autistic and ADHD difficulties may explain elevated rates of depression in the neurodevelopmental group.

Sections du résumé

BACKGROUND
Children with neurodevelopmental disorders are at increased risk of developing depression. Irritability predicts depression in the general population and is common in children with neurodevelopmental disorders. Thus, it is possible that irritability in children with neurodevelopmental disorders contributes to the link with later depression. This study aimed to (a) examine the association between childhood neurodevelopmental difficulties and adolescent depression and (b) test whether irritability explains this association.
METHODS
Children with any neurodevelopmental difficulty at the age of 7-9 (n = 1,697) and a selected, comparison group without any neurodevelopmental difficulty (n = 3,177) were identified from a prospective, UK population-based cohort, the Avon Longitudinal Study of Parents and Children. Neurodevelopmental difficulties were defined as a score in the bottom 5% of the sample on at least one measure of cognitive ability, communication, autism spectrum symptoms, attention-deficit/hyperactivity symptoms, reading or motor coordination. The Development and Well-Being Assessment measured parent-reported child irritability at the age of 7, parent-reported adolescent depression at the age of 10 and 13, and self-reported depression at the age of 15. Depression measures were combined, deriving an outcome of major depressive disorder (MDD) in adolescence. Logistic regression examined the association between childhood neurodevelopmental difficulties and adolescent MDD, controlling for gender. Path analysis estimated the proportion of this association explained by irritability. Analyses were repeated for individual neurodevelopmental problems.
RESULTS
Childhood neurodevelopmental difficulties were associated with adolescent MDD (OR = 2.11, 95% CI = 1.24, 3.60, p = .006). Childhood irritability statistically accounted for 42% of this association. On examining each neurodevelopmental difficulty separately, autistic, communication and ADHD problems were each associated with depression, with irritability explaining 29%-51% of these links.
CONCLUSIONS
Childhood irritability appears to be a key contributor to the link between childhood neurodevelopmental difficulties and adolescent MDD. High rates of irritability in children with autistic and ADHD difficulties may explain elevated rates of depression in the neurodevelopmental group.

Identifiants

pubmed: 30908655
doi: 10.1111/jcpp.13053
pmc: PMC6767365
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

866-874

Subventions

Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Références

J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):377-84
pubmed: 25901774
J Child Psychol Psychiatry. 2004 Feb;45(2):212-29
pubmed: 14982237
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
J Am Acad Child Adolesc Psychiatry. 2010 May;49(5):484-92
pubmed: 20431468
Am J Psychiatry. 2013 Feb;170(2):173-9
pubmed: 23377638
Am J Psychiatry. 2009 Sep;166(9):1048-54
pubmed: 19570932
Braz J Psychiatry. 2013;35 Suppl 1:S32-9
pubmed: 24142126
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Pediatrics. 2009 Apr;123(4):e693-700
pubmed: 19336359
J Abnorm Psychol. 2014 Nov;123(4):841-51
pubmed: 25314267
Lancet Psychiatry. 2017 Apr;4(4):339-346
pubmed: 27979720
J Child Psychol Psychiatry. 2009 Mar;50(3):216-23
pubmed: 19166573
J Child Psychol Psychiatry. 1998 Sep;39(6):879-91
pubmed: 9758196
Acta Psychiatr Scand. 2004 Dec;110(6):408-15
pubmed: 15521824
Br J Psychiatry. 2005 Dec;187:568-72
pubmed: 16319410
J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):961-9
pubmed: 23972698
J Clin Psychiatry. 2014 Feb;75(2):e108-13
pubmed: 24602257
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
J Learn Disabil. 2016 Mar-Apr;49(2):130-9
pubmed: 24733818
J Autism Dev Disord. 2009 Jun;39(6):827-33
pubmed: 19132522
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Affect Disord. 2017 Jun;215:281-287
pubmed: 28363151
J Am Acad Child Adolesc Psychiatry. 2013 Apr;52(4):389-400.e1
pubmed: 23582870
J Child Psychol Psychiatry. 2001 May;42(4):487-92
pubmed: 11383964
J Abnorm Child Psychol. 2014 Feb;42(2):291-300
pubmed: 23860740
J Am Acad Child Adolesc Psychiatry. 2008 Apr;47(4):426-434
pubmed: 18388760
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Pediatrics. 2011 Jun;127(6):1034-42
pubmed: 21606152
J Autism Dev Disord. 2012 Jul;42(7):1353-63
pubmed: 21960455
Mol Psychiatry. 2018 Feb;23(2):257-262
pubmed: 28242872
J Abnorm Child Psychol. 2012 May;40(4):595-606
pubmed: 22113705
J Am Acad Child Adolesc Psychiatry. 2016 Jul;55(7):556-70
pubmed: 27343883
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):404-412
pubmed: 19318881
J Abnorm Psychol. 2010 Nov;119(4):726-38
pubmed: 21090876
J Abnorm Child Psychol. 2016 May;44(4):787-97
pubmed: 26272531
Am J Psychiatry. 2012 Jan;169(1):47-54
pubmed: 22193524
Soc Psychiatry Psychiatr Epidemiol. 2011 Jun;46(6):521-32
pubmed: 20376427
Am J Psychiatry. 2014 Mar;171(3):276-93
pubmed: 24480998
J Am Acad Child Adolesc Psychiatry. 2017 Feb;56(2):167-174.e1
pubmed: 28117063
J Atten Disord. 2005 May;8(4):195-207
pubmed: 16110050
Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38
pubmed: 24942707
J Autism Dev Disord. 2003 Aug;33(4):365-82
pubmed: 12959416
J Abnorm Child Psychol. 2014 May;42(4):611-21
pubmed: 24221724
J Child Adolesc Psychopharmacol. 2008 Dec;18(6):565-71
pubmed: 19108661
J Child Psychol Psychiatry. 2014 Oct;55(10):1162-71
pubmed: 24673629
J Child Psychol Psychiatry. 2012 Nov;53(11):1157-66
pubmed: 22909395
J Affect Disord. 2013 Feb 15;145(1):70-6
pubmed: 22868057
Am J Med Genet. 2000 Jun 12;96(3):293-301
pubmed: 10898903
Clin Psychol Rev. 2017 Apr;53:29-45
pubmed: 28192774
J Autism Dev Disord. 2002 Aug;32(4):299-306
pubmed: 12199134

Auteurs

Olga Eyre (O)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Rachael A Hughes (RA)

MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Ajay K Thapar (AK)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Ellen Leibenluft (E)

Emotion and Development Branch, National Institute of Mental Health, Bethesda, MD, USA.

Argyris Stringaris (A)

Emotion and Development Branch, National Institute of Mental Health, Bethesda, MD, USA.

George Davey Smith (G)

MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Evie Stergiakouli (E)

MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
School of Oral and Dental Sciences, University of Bristol, Bristol, UK.

Stephan Collishaw (S)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Anita Thapar (A)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH